Employee Benefit Plans (Tables)

6 Months Ended

Dec. 31, 2023

Share-Based Payment Arrangement, Noncash Expense [Abstract]

Common Stock Reserved for Future Issuance

The Company had the following reserved shares of common stock for future issuance as of the dates noted (in thousands):

	December 31, 2023		June 30, 2023
2013 Equity Incentive Plan shares available for grant		12,634		9,995
Employee stock options and awards outstanding		8,875		10,038
2014 Employee Stock Purchase Plan		7,948		8,467
Total shares reserved for issuance		29,457		28,500

Schedule of Recognized Share-based Compensation Expense

Share-based compensation expense recognized in the condensed consolidated financial statements by line-item caption is as follows (in thousands):

	Three Months Ended				Six Months Ended
	December 31, 2023		December 31, 2022		December 31, 2023		December 31, 2022
Cost of product revenues	$	464	$	499	$	947	$	873
Cost of subscription and support revenues		749		966		1,615		1,638
Research and development		4,435		3,962		8,812		7,052
Sales and marketing		7,535		5,910		14,523		10,549
General and administrative		7,774		6,059		14,979		11,073
Total share-based compensation expense	$	20,957	$	17,396	$	40,876	$	31,185

Summary of Stock Option Activity

The following table summarizes stock option activity for the six months ended December 31, 2023 (in thousands, except per share amount and contractual term):

	Number of Shares			Weighted-Average Exercise Price Per Share		Weighted-Average Remaining Contractual Term (years)		Aggregate Intrinsic Value
Options outstanding at June 30, 2023		1,187		$	6.56		2.70	$	23,136
Granted		—			—
Exercised		(57	)		6.40
Canceled		—			—
Options outstanding at December 31, 2023		1,130		$	6.57		2.22	$	12,513
Vested and expected to vest at December 31, 2023		1,130		$	6.57		2.22	$	12,513
Exercisable at December 31, 2023		1,130		$	6.57		2.22	$	12,513

Summary of Stock Award Activity

The following table summarizes stock award activity for the six months ended December 31, 2023 (in thousands, except grant date fair value):

	Number of Shares			Weighted- Average Grant Date Fair Value		Aggregate Fair Value
Non-vested stock awards outstanding at June 30, 2023		8,851		$	14.25
Granted		3,553			29.30
Released		(4,114	)		12.57
Canceled		(545	)		17.51
Non-vested stock awards outstanding at December 31, 2023		7,745		$	21.81	$	168,918
Stock awards expected to vest at December 31, 2023		7,745		$	21.81	$	168,918

Schedule of Awards Performance Thresholds and Shares Expected to Vest (TSR PSUs)

The MSU award represents the right to receive a target number of shares of common stock of up to 150% of the original grant, as indicated in the table below. The MSUs vest based on the Company’s TSR relative to the TSR of the Index over performance periods of three years from the grant date, subject to the grantees’ continued service through the certification of performance.

Level	Relative TSR	Shares Vested
Below Threshold	TSR is less than the Index by more than 37.5 percentage points	0%
Threshold	TSR is less than the Index by 37.5 percentage points	25%
Target	TSR equals the Index	100%
Maximum	TSR is greater than the Index by 25 percentage points or more	150%

Schedule of Fair Value Assumptions for Employee Stock Purchase Plan Awards

The following assumptions were used to determine the grant-date fair values of the ESPP shares during the following periods:

	Employee Stock Purchase Plan
	Six Months Ended
	December 31, 2023			December 31, 2022
Expected term	0.5 years			0.5 years
Risk-free interest rate		5.54	%		3.12	%
Volatility		42	%		60	%
Dividend yield		—	%		—	%